Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Adjuvant/Neoadjuvant

Reinhard Dummer

MD

🏢University Hospital Zurich🌐Switzerland

Vice Chairman, Department of Dermatology

82
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Reinhard Dummer is a leading melanoma researcher who has been pivotal in developing BRAF/MEK-targeted adjuvant and neoadjuvant strategies. He led key trials of encorafenib-binimetinib and contributed to establishing dabrafenib-trametinib as adjuvant therapy for BRAF-mutant melanoma. His dermatologic oncology expertise spans the full spectrum of skin cancer treatment.

Share:

🧪Research Fields 研究领域

Melanoma
BRAF/MEK inhibitors
Adjuvant targeted therapy
Dermatologic oncology
Skin cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Reinhard Dummer 的研究动态

Follow Reinhard Dummer's research updates

留下邮箱,当我们发布与 Reinhard Dummer(University Hospital Zurich)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment